Use of simalikalactone E as an anticancer agent
US8987324B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2012 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Jan 13, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to Simalikalactone E (SkE) to be used for preventing and/or treating cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.